Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Twilio Inc (TWLO) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

Twilio IncTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

Twilio Inc vs DENTSPLY SIRONA Inc — how do they compare? Twilio Inc trades at $277.18 (market cap $42.35B), while DENTSPLY SIRONA Inc trades at $8.78 (market cap $1.73B). The key difference: Twilio Inc is far larger — about 24.5× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Twilio Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Twilio Inc for 56 Days and DENTSPLY SIRONA Inc for 72 Days on average.

TWLOXRAY
Market Cap
$42.35B$1.73B
Volume
1,862,6426,198,582
Sector
TechnologyHealth
52-Week High
$301.27$14.68
52-Week Low
$106.23$8.52
Typical Hold Time
56 Days72 Days
Enterprise Value
$40.76B$3.80B
Dividend Yield
—5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Twilio Inc

Twilio (TWLO) trades at $273.00, down 2.64% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong revenue growth to $5.07 billion in 2025, turning profitable with a net income of $33.83 million, and has beaten EPS estimates for three consecutive quarters. Recent inclusion in the S&P 500 index and positive analyst sentiment highlight its market position.

Outlook remains positive driven by accelerating revenue growth and Voice AI expansion, but risks include high valuation multiples and competitive pressures. Analyst consensus is bullish with a $254.65 price target, though recent insider selling and a high P/E of 38.09 warrant caution for value-focused investors.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $8.54, near its 52-week low, with bearish technical indicators and mixed fundamentals. The company reported Q2 2026 EPS of $0.52 beating expectations but revenue declined 4.1% year-over-year. Net income remains negative at -$598 million for 2025, though margins show slight improvement. Analyst consensus is mixed with 37.5% buy ratings but a $13.40 price target suggesting 57% upside potential from current levels.

The stock presents a high-risk turnaround opportunity with significant upside if management's restructuring efforts succeed, but faces headwinds from declining sales, margin pressure, and competitive challenges in dental markets. Institutional ownership changes and ongoing transformation investments create both uncertainty and potential for recovery.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TWLO
51% Buy49% Sell
Avg holding period · 56 Days
XRAY

No sentiment data available yet.

Top news

Latest headlines on both assets

About Twilio Inc

Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.

Read more on TWLO →

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY →